Heart palpitations are not listed among the common side effects of the shingles vaccine, but some people do notice a racing or pounding heartbeat in the hours after getting the shot. Research into the vaccine’s adjuvant system shows that temporary heart-rate increases can accompany the strong immune reaction Shingrix is designed to trigger, though median heart rates stayed within normal bounds even at their peak. The distinction between that kind of fleeting physical stress response and a genuine cardiac event matters, and the large-scale safety data on the vaccine is reassuring on the cardiac front.
What Clinical Trials Found About Side Effects
Shingrix (the recombinant zoster vaccine, or RZV) is known for producing more side effects than many other vaccines. That is not an accident; it is a direct consequence of the powerful adjuvant system the vaccine uses to provoke a strong, lasting immune response. In a phase 3 trial of adults aged 50 and older, about 72% of vaccine recipients reported at least one expected side effect, compared with roughly 59% in the placebo group. The vast majority of those reactions were mild to moderate, and no serious adverse events related to the vaccine were reported.1Vaccine. Immune response and safety of the adjuvanted recombinant zoster vaccine in adults 50 years of age and older in India: A randomized phase 3 trial
The side effects most commonly tracked in these trials are injection-site pain, redness, and swelling, along with systemic symptoms like fatigue, muscle aches, headache, and fever. Heart palpitations do not appear as a standard solicited adverse event category in the major Shingrix trials. That does not mean nobody experiences them; it means palpitations were not frequent enough, or consistently enough separated from other symptoms, to be flagged as a distinct finding. Compared with the older live shingles vaccine (Zostavax), Shingrix has similar types of systemic side effects but tends to produce them more frequently, a trade-off for its higher and longer-lasting effectiveness.2PubMed Central. Recombinant zoster vaccine (Shingrix®): a new option for the prevention of herpes zoster and postherpetic neuralgia
Why Your Heart Might Race After the Shot
Shingrix uses an adjuvant called AS01B, which is responsible for much of the vaccine’s reactogenicity. The adjuvant amplifies the immune response, but in the process, it triggers a cascade of inflammation that can include fever, chills, and general achiness. A detailed study measuring the physiological effects of AS01B (in a hepatitis B vaccine that uses the same adjuvant system) found that body temperature and heart rate both peaked around 18 hours after the second dose. About 30% of people who received the AS01B-adjuvanted vaccine developed a fever after the second dose, and heart rate reached its highest point at the same time as the fever peak.3Vaccine. Inflammatory parameters associated with systemic reactogenicity following vaccination with adjuvanted hepatitis B vaccines in humans
This makes physiological sense. When your body temperature rises, your heart speeds up to keep blood circulating efficiently and to support the immune response your body is mounting. For every degree Fahrenheit of fever, heart rate typically increases by several beats per minute. If you are lying in bed at night with post-vaccine chills and a low-grade fever, a heart rate that feels faster than usual is the body doing exactly what it is supposed to do. Importantly, the study found that median heart rate remained within the normal range at every time point measured, even at the peak.3Vaccine. Inflammatory parameters associated with systemic reactogenicity following vaccination with adjuvanted hepatitis B vaccines in humans The sensation of palpitations does not require your heart rate to be dangerously high. Even a modest increase from your resting rate can feel noticeable, especially if you are already tired, slightly dehydrated, or anxious about having received the vaccine.
The inflammatory response following Shingrix is also more pronounced after the second dose than the first, which tracks with the study’s finding that the heart-rate and temperature spikes were more prominent after the second injection. So if you got through the first dose without feeling much, a stronger reaction the second time around, including a pounding heart, would not be unusual.
Anxiety and Heightened Body Awareness
One factor that gets underappreciated in vaccine side-effect discussions is the role of awareness and anxiety. The act of getting a vaccination, especially one you have heard causes strong side effects, primes you to pay close attention to every physical sensation afterward. Heart palpitations are among the most commonly reported symptoms by anxious people in general, not just after vaccination. The combination of anticipatory nervousness, a real but mild inflammatory response, and the tendency to monitor your body closely can produce the subjective experience of palpitations even when heart rhythm and rate are completely normal.
This is not the same as saying the sensation is “all in your head.” Anxiety produces real physiological changes: adrenaline release increases heart rate, and stress can alter the pattern of heartbeats in ways people can feel. But it does mean that some proportion of post-vaccine palpitation reports reflect the stress of the experience rather than a direct pharmacological effect of the vaccine itself. When large populations receive a vaccine and are asked to report anything unusual over the following days, palpitations reliably show up in the data for virtually every vaccine studied, including placebos in clinical trials.
Large-Scale Cardiovascular Safety Data
The most compelling evidence on whether Shingrix causes cardiac problems comes from population-level surveillance, where researchers can look at millions of vaccinated people and compare their rates of heart events with unvaccinated populations. A large study published in Nature Medicine examined cardiovascular outcomes in the period after the United States transitioned from the older live shingles vaccine to the recombinant vaccine. Rather than finding increased cardiac risk, the study found that the group predominantly receiving the recombinant vaccine had a roughly 7% lower burden of atrial fibrillation compared to what would have been expected. The study found no significant association between the recombinant shingles vaccine and myocarditis, peripheral arterial disease, hemorrhagic stroke, or transient ischemic attack.
These are exactly the kinds of signals that population surveillance is designed to detect. If Shingrix were causing meaningful rates of serious heart problems, studies of this size would pick them up. The fact that they instead found either neutral or slightly favorable cardiovascular trends is strong evidence that the vaccine is not driving cardiac events. The temporary pounding heart some people feel in the 24 to 48 hours after vaccination appears to be part of the body’s acute inflammatory response, not a marker of underlying heart damage.
Distinguishing Normal Reactions from Concerning Symptoms
Given that some degree of heart-rate increase is a predictable part of the immune response to Shingrix, when should you actually worry? The general pattern of a normal post-vaccine reaction follows a predictable arc: symptoms start within 6 to 12 hours, peak at around 18 to 24 hours, and resolve within two to three days. A racing heart that follows this timeline and accompanies other typical symptoms like fatigue, mild fever, and muscle aches is almost certainly just your immune system at work.
Symptoms that warrant a call to your doctor or a trip to urgent care include:
- Chest pain: Especially if it feels like pressure, squeezing, or tightness rather than a general achiness.
- Persistent irregularity: A heart that feels like it is skipping beats, fluttering erratically, or beating in an irregular pattern, as opposed to simply beating fast.
- Shortness of breath: Difficulty breathing that is not explained by fever alone and feels disproportionate to your activity level.
- Symptoms beyond 72 hours: Most Shingrix side effects resolve within a few days. Palpitations that persist well past the 48- to 72-hour window deserve investigation.
- Fainting or near-fainting: Feeling lightheaded when standing is not unusual with fever and dehydration, but actually blacking out or coming very close is a different category.
If you have a known heart condition, an arrhythmia, or are on cardiac medications, mention the vaccination to your cardiologist. There is no established contraindication to Shingrix for people with heart disease, but your doctor can help you interpret any symptoms in the context of your specific history.
Autonomic Effects After Vaccination
A small number of people report symptoms after vaccination that go beyond a day or two of racing heart and resemble a condition called postural orthostatic tachycardia syndrome, or POTS. In POTS, the autonomic nervous system, which controls involuntary functions like heart rate and blood pressure, does not regulate itself properly when you change positions. Standing up can trigger a dramatic spike in heart rate, along with dizziness, palpitations, and fatigue.
Most of the published literature on vaccine-triggered POTS involves COVID-19 vaccines rather than the shingles vaccine. Case reports have described patients developing fatigue, palpitations, dizziness, and near-fainting episodes starting within about a week of COVID vaccination, with heart rates jumping to around 120 beats per minute.4PubMed Central. COVID-19 Vaccination Might Induce Postural Orthostatic Tachycardia Syndrome: A Case Report Whether the same phenomenon occurs with Shingrix at any measurable rate is not established. The mechanism proposed for vaccine-triggered POTS involves the immune system cross-reacting with components of the autonomic nervous system, and it remains poorly understood and quite rare regardless of which vaccine is involved.
If your palpitations are specifically triggered by standing up, accompanied by dizziness and fatigue that do not resolve after the normal post-vaccine window, and you notice your heart rate jumping dramatically when you move from sitting to standing, it is worth raising the pattern with your doctor. A simple in-office standing test can screen for POTS.
Shingles Itself Is a Heart Risk
An irony in the conversation about vaccine-related heart symptoms is that the disease the vaccine prevents, herpes zoster (shingles), is a well-documented risk factor for serious cardiovascular events. A large pooled analysis following over two million person-years of data found that people who had experienced a shingles outbreak had a significantly elevated risk of both stroke and coronary heart disease in the years that followed. The risk of stroke was roughly 38% higher in the five-to-eight-year window after a shingles episode, and coronary heart disease risk was about 25% higher in the nine-to-twelve-year window.5Journal of the American Heart Association. Herpes Zoster and Long-Term Risk of Cardiovascular Disease
The mechanism is thought to involve the inflammation triggered by viral reactivation. When varicella-zoster virus reactivates along nerve pathways, it does not just cause pain and blisters; it provokes a broader inflammatory response that can affect blood vessels. Over time, this may contribute to plaque instability in arteries, increased blood-clotting tendency, and vascular damage. The cardiovascular risk does not appear to spike right after a shingles outbreak and then disappear; it builds over years, with the strongest effects appearing roughly a half-decade later.5Journal of the American Heart Association. Herpes Zoster and Long-Term Risk of Cardiovascular Disease
Vaccination and Long-Term Heart Protection
The relationship runs in the other direction as well. Observational research from a study of over a million people in South Korea found that those who received the live shingles vaccine were roughly 26% less likely to die from heart disease or experience a stroke, heart attack, or heart failure compared with unvaccinated individuals. The protective effect appeared to last for up to eight years, with the greatest reduction seen in the first two to three years after vaccination.6BMJ. Live shingles vaccine linked to lower risk of heart disease
These are observational findings, meaning people who choose to get vaccinated may differ from those who do not in ways that also affect heart health, such as being more engaged with preventive care generally. Researchers adjusted for many of those factors, but residual confounding is always a possibility with this type of study. Still, the direction and size of the effect are consistent with what you would expect if preventing shingles also prevented the downstream vascular inflammation that shingles causes.
The implication is worth spelling out: a day or two of feeling lousy after Shingrix, including an uncomfortably fast heartbeat, is a trade-off against a disease that independently raises your risk of heart attack and stroke for years. The temporary palpitations are part of an immune response that is actively building protection against something that could damage your cardiovascular system far more meaningfully down the road.
People With Pre-Existing Heart Conditions
If you already have atrial fibrillation, a history of arrhythmia, heart failure, or coronary artery disease, the prospect of getting a vaccine known for strong reactogenicity can feel daunting. The available evidence does not suggest that people with cardiac conditions face an elevated risk of serious events from Shingrix. The population-level data showing neutral-to-favorable cardiovascular outcomes included older adults, the very group most likely to have pre-existing heart disease. And the clinical trials that established the vaccine’s safety profile were conducted in adults 50 and older, many of whom had common chronic conditions.
That said, if you are on blood thinners, beta-blockers, or antiarrhythmic medications, a day of heightened inflammatory response can theoretically interact with how your body handles heart rate and rhythm. Staying hydrated, avoiding strenuous activity for a day or two after the shot, and having a plan for managing fever with acetaminophen or ibuprofen (as appropriate for your medical situation) are reasonable steps. Some people find it helpful to schedule the vaccine for a day when they can rest the following day, particularly before the second dose, which tends to produce a stronger reaction.
For people with implanted cardiac devices like pacemakers or defibrillators, there is no known interaction with Shingrix. The vaccine does not affect electromagnetic fields, and the inflammatory response it triggers is systemic, not localized to the heart. Your device will continue to monitor and respond to your heart rhythm normally. If your device does log an episode of tachycardia in the day or two after vaccination, it is worth mentioning at your next cardiology appointment, but it is likely to reflect the same benign, fever-driven heart-rate increase seen in the general population.